Healthcare Global Enterprises Ltd. · NSE:HCG

Healthcare Global Enterprises — Q4 FY2016 Earnings Presentation

15 slides from Healthcare Global Enterprises's earnings presentation, May 2016

  1. Slide 1: Q4 and FY2016 – Earnings Update

    Healthcare Global Enterprises Limited Q4 and FY2016 – Earnings Update May 2016

  2. Slide 2: Disclaimer

    Disclaimer THIS PRESENTATION AND ITS CONTENTS ARE CONFIDENTIAL AND ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION WHERE SUCH DISTRIBUTION IS UNLAWFUL. This pr

  3. Slide 3: Contents

    Contents  Financial Highlights  Operational Highlights  Consolidated Financial Results  Update on New Centres 3

  4. Slide 4: Financial Highlights: Q4 FY16

    Financial Highlights: Q4 FY16 Strong Growth in Revenue, EBITDA and PAT INR million except per share data Growth • Revenue grew 16.3% y-o-y Period ended March 31 Q4-FY16 Q4-FY15 (y-o-y) • HCG(1) centres: +15.5% y-o-y Income from Operations 1,537.5 1,321.7 16.3% • Milann(2) centres: +25.7% y-o-y EBITD

  5. Slide 5: Financial Highlights: FY 2016

    Financial Highlights: FY 2016 Growth in revenues and margins across centres INR million except per share data Growth • Revenue grew 12.1% Period ended March 31 FY16 FY15 (y-o-y) • HCG(1) centres: +11.9% Income from Operations 5,819.8 5,193.8 12.1% • Milann(2) centres: +14.4% EBITDA(1) 896.6 762.5 17

  6. Slide 6: Operating Highlights: Revenue Break-up (FY2016)

    Operating Highlights Revenue Break-up (FY2016) Consolidated FY16 Revenue: HCG Centres FY16 Revenue: INR 5,820 Mn INR 5,358 Mn Karnataka HCG (1) 49% Centres 92% Gujarat 26% Fertility Centres 8% Andhra (2) Pradesh 3% Maharashtra East India 4% 8% North India Tamil Nadu 5% 5% 1. Centres operated under t

  7. Slide 7: HCG Centres: Strong Growth From Centres Across India

    HCG Centres Strong Growth From Centres Across India Q4 – FY16 FY 2016 INR million INR million Growth Growth Period ended March 31 Q4-FY16 Q4-FY15 (y-o-y) Period ended March 31 FY16 FY15 (y-o-y) Karnataka 695 606 14.7% Karnataka 2,613 2,415 8.2% Gujarat 381 291 31.0% Gujarat 1,363 1,095 24.5% East In

  8. Slide 8: HCG Centres: Operating Metrics

    HCG Centres Operating Metrics Growth Growth Q4-FY16 Results Period ended March 31 Q4-FY16 (y-o-y) FY16 (y-o-y) • Occupied Bed Days: +11% • 3.9% increase in ARPOB No. of Centres 17 17 • Ahmedabad, Cuttack, Chennai and Beds 1,146 15.4% 1,146 15.4% Vijayawada centres primary drivers of growth Occupied

  9. Slide 9: Operating Highlights

    Operating Highlights Strong Growth in and Expansions at Ahmedabad and Cuttack Karnataka Q4 FY16 Q4 FY15 Growth FY 16 FY 15 Growth No of Centres 6 5 6 5 Beds 563 459 563 459 • Addition of OT’s, bed capacity and PET-CT Occupied Bed Days 24,510 23,428 4.6% 92,298 97,911 -5.7% at Hubli AOR 47.8% 56.1% 5

  10. Slide 10: Bangalore – KR and DR Centres

    Bangalore – KR and DR Centres Improving trend with Q4 ROCE above 20% Overview  Established in 1989. Centre of Excellence created in 2006.  83 oncologists, 50+ other specialist physicians Key Facilities  4 Linear Accelerators (incl. Cyberknife and TomoTherapy radiotherapy systems)  2 PET-CT Scann

  11. Slide 11: Operating Highlights: Milann commences national expansion

    Operating Highlights Milann commences national expansion • Growth in revenues driven by increased Q4 FY 16 Q4 FY 15 Growth (y-o-y) procedure volume New Registrations 1,122 1,023 9.7% • First centre outside Bangalore opened in IVF cycles 340 284 19.7% South Delhi in Q4-FY16 Revenue 119 96 24.5% • Mil

  12. Slide 12: Capital Expenditures

    Capital Expenditures Expansions and New Centres primary drivers of FY16 CapEx (INR Million) FY15 FY16 Cancer Centres Cancer Centres Existing Centres 362 339 • Maintenance CapEx of INR 339 Mn Expansions 173 528 • Expansions, technology enhancements New Centres 480 (1) 1,250 completed at Hubli, KR/DR,

  13. Slide 13: Net Debt Position – FY 2016

    Net Debt Position – FY 2016 Year of capex / expansion along with reduction of debt through IPO proceeds As at As at As at As at As at INR Million 31-Mar-15 30-Jun-15 30-Sep-15 31-Dec-15 31-Mar-16 Net Debt (1) (1) (1) (1) Bank Debt 1,983 1,983 2,199 2,145 694 • IPO proceeds of INR DPO 650 683 1,050 1

  14. Slide 14: Project Update

    Project Update INR in millions 3 New Cancer Centres operational as of May 2016 3 New Milann Fertility Centres will be Additional 3 Cancer Centres will be operational by March 2017 operational by March 2017 Bed Project Expected Location Start Date Location Capacity Cost Start Date Gulbarga, Karnataka

  15. Slide 15: THANK YOU

    THANK YOU www.hcgel.com investors@hcgoncology.com 15

Healthcare Global Enterprises — Q4 FY2016 Earnings Presentation on 6ix